Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122511) titled 'Neoadjuvant EGFR-ADC plus PD-1 Inhibitor for Locally Advanced Oral Squamous Cell Carcinoma: A Prospective, Single-Arm Study' on April 14.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Peking University School of Stomatology

Condition: Oral Squamous Cell Carcinoma

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-04-14

Target Sample Size: Experiment Group:50;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=317580

Disclaimer: Curated by HT Syndication....